logo
Plus   Neg
Share
Email
Comment

Select Medical Holdings Q1 Profit Rises; Backs FY12 Outlook - Quick Facts

Select Medical Holdings Corp. (SEM) reported first-quarter net income attributable to the company of $41.5 million or $0.29 per share, compared to $33.7 million or $0.22 per share last year.

On average, eight analysts polled by Thomson Reuters expected earnings of $0.25 per share for the quarter. Analysts' estimate typically excludes one-time items.

Net operating revenues for the quarter increased 7.3 percent to $744.02 million from $693.19 million in the same quarter last year, while seven analysts estimated revenues of $720.43 million for the quarter.

Looking forward, the company expects income per share for full year 2012 to be in the range of $0.86 to $0.94 and consolidated revenue in the range of $2.85 billion to $2.95 billion. Analysts currently expect earnings of $0.90 per share and revenue of $2.91 billion for the full year.

Further, the board of directors of Select Medical authorized an increase of $100.0 million in the capacity of its common stock repurchase program from $150.0 million to $250.0 million. The program will remain in effect until March 31, 2013, unless extended by the board of directors.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amid a government shutdown, the Senate voted Monday to move forward on a short-term spending bill to re-open the government. The Senate voted 81 to 18 in favor of limiting debate on the bill, which would fund the government through February 8th. Opera, a web browser for Windows, macOS, and Linux operating systems, has added cryptocurrency mining protection to its mobile browsers. It is part of the browser's ad blocker function. In its desktop-based versions, Opera had introduced cryptocurrency miner protection in early January. French drug giant Sanofi SA Monday announced an agreement to buy US-based hemophilia drugmaker Bioverativ Inc. (BIVV) for around $11.6 billion. The deal expands Sanofi's presence in specialty care and strengthens leadership in rare diseases. Sanofi shares were losing around 4 percent in the early morning trading in Paris.
comments powered by Disqus
Follow RTT